ArticleGenes2024

The Role of IRF9 Upregulation in Modulating Sensitivity to Olaparib and Platinum-Based Chemotherapies in Breast Cancer.

SeokGyeong Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.